NCT06709807View on ClinicalTrials.gov

Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

December 7, 2024

Study Completion Date

December 19, 2024

Conditions
Type 2 Diabetes Mellitus (T2DM)
Interventions
DRUG

CKD-378 25/1000mg

QD, PO

Trial Locations (1)

08779

H Plus Yangji Hospital, Gwanak-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY